A comparative study of Tc-99(m)-d,l-HMPAO and Tc-99(m)-d,l-CBPAO as leukocyte-labelling agents

被引:5
作者
Tsai, CS [1 ]
Kao, CH [1 ]
Yeh, SJ [1 ]
Wang, SJ [1 ]
机构
[1] TAICHUNG VET GEN HOSP,DEPT NUCL MED,TAICHUNG 40705,TAIWAN
关键词
D O I
10.1097/00006231-199601000-00013
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
An attempt was made to use Tc-99(m)-d,l-cyclobutylpropylene amine oxime (Tc-99(m)-d,l-CBPAO) to label leukocytes. The radiochemical purity of Tc-99(m)-d,l-CBPAO, labelling efficiency of leukocytes, cell viability of labelled leukocytes and stability of Tc-99(m)-d,l-CBPAO-labelled leukocytes were calculated. In comparison with the commercial cell-labelling agent Tc-99(m)-d,l-hexamethylpropylene amine oxime (Tc-99(m)-d,l-HMPAO), (1) the radiochemical purity of Tc-99(m)-d,l-CBPAO was higher than that of Tc-99(m)-d,l-HMPAO immediately after and 1, 2, 4, 6, 8 and 24 h after Tc-99(m) labelling; (2) the labelling efficiency of Tc-99(m)-d,l-CBPAO-labelled leukocytes was lower than that of Tc-99(m)-d,l-HMPAO; (3) the viability of labelled white blood cells was high for both agents; and (4) the stability of Tc-99(m)-d,l-CBPAO-labeIled leukocytes was better than that of Tc-99(m)-d,l-HMPAO after 1, 2, 4, 6, 8 and 24 h. In conclusion, although the labelling efficiency of Tc-99(m)-d,l-CBPAO is lower, it is more stable than Tc-99(m)-d,l-HMPAO and provides greater stability of Tc-99(m)-d,l-CBPAO-labeIled leukocytes. Therefore, Tc-99(m)-d,l-CBPAO has the potential to replace Tc-99(m)-d,l-HMPAO as a commercial leukocyte-labelling agent.
引用
收藏
页码:76 / 79
页数:4
相关论文
共 16 条
[1]   EVALUATION OF TECHNETIUM 99M CYCLOBUTYLPROPYLENE AMINE OXIME AS A POTENTIAL BRAIN PERFUSION IMAGING AGENT FOR SPET [J].
BACCIOTTINI, L ;
LUNGHI, F ;
PUPI, A ;
BONINO, C ;
FORMICONI, AR ;
DECRISTOFARO, MTR ;
PETTI, ARM ;
MELDOLESI, U .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1990, 17 (05) :242-247
[2]   COMPARISON OF TC-99M-HMPAO AND IN-111-OXINE LABELED GRANULOCYTES IN MAN - 1ST CLINICAL-RESULTS [J].
BECKER, W ;
SCHOMANN, E ;
FISCHBACH, W ;
BORNER, W ;
GRUNER, KR .
NUCLEAR MEDICINE COMMUNICATIONS, 1988, 9 (06) :435-447
[3]  
COLASLINHART N, 1984, BLOOD CELLS NUCL M 2, P117
[4]  
COLOMBO F, 1990, TECHNETIUM RHENIUM C, P469
[5]  
HUNG JC, 1989, NUCL MED BIOL, V16, P675
[6]   A COMPARATIVE-STUDY OF 99TCM-HMPAO AND 99TCM-ECD AS A LEUKOCYTE LABELING AGENT [J].
KAO, CH ;
HUANG, WT ;
WANG, YL ;
LIN, KS ;
LO, JM ;
WANG, SJ .
NUCLEAR MEDICINE COMMUNICATIONS, 1994, 15 (04) :294-297
[7]  
KAO CH, 1992, J NUCL MED TECHNOL, V20, P224
[8]  
LANTTO EH, 1991, J NUCL MED, V32, P2029
[9]  
MCAFEE JG, 1976, J NUCL MED, V17, P480
[10]  
MCAFEE JG, 1976, J NUCL MED, V17, P488